Global Clinical Trials Industry Forecasted to Attain US$ 177.7 Billion by 2033, Averaging a 4.41% CAGR Triumph | FMI

By the end of 2023, the Global Clinical Trials Industry is anticipated to be worth US$ 115.4 billion, and it will grow at a CAGR of 4.41% to reach US$ 177.7 billion by the year 2033. Industry sponsors are in the lead with a predicted market share of about 54.7% in 2023, according to a recent …

Global Clinical Trials Industry Set to Surge, Aiming for US$ 177.7 Billion by 2033, at a CAGR of 4.41% | FMI

n a recent study conducted by Future Market Insights (FMI), the Global Clinical Trials Industry is on the verge of remarkable growth. It is projected to reach a valuation of approximately US$ 115.4 billion by the end of 2023 and is poised for further expansion at a robust CAGR of 4.41%. The market’s upward trajectory …

Eclinical Solutions And Software Industry Set for Explosive Growth, Expected to Hit US$29.1 Billion by 2033 with 12.1% CAGR | FMI

The global Eclinical Solutions And Software Market is anticipated to reach a valuation of US$ 29.1 billion in 2033, rising up from an estimated US$ 9.3 billion in 2023. Valued at US$ 8.4 billion in 2022, the market witnessed a CAGR of 10.6% from 2017 to 2022. It is gauged that the eClinical solutions and software market …